Trump administration authorises 172 million barrel SPR drawdown as 32 IEA nations coordinate record emergency oil release
Read More 5 minute read Pharma Industry News Is Ocular Therapeutix the next big biotech buyout? Takeover rumors spark investor frenzy Ocular Therapeutix stock jumps on takeover rumors. Find out what analysts are saying, and why Axpaxl could make it biotech’s next big M&A target. byPallavi MadhirajuSeptember 7, 2025